Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5949 | 1484 | 34.9 | 56% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
214 | 20119 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY | Journal | 2 | 12% | 1% | 15 |
2 | J11D | Author keyword | 1 | 50% | 0% | 1 |
3 | MED ICRF HUMAN TUMOUR IMMUNOL GRP | Address | 1 | 50% | 0% | 1 |
4 | MENINGOCOCCAL GROUP C POLYSACCHARIDE | Author keyword | 1 | 50% | 0% | 1 |
5 | T CELL REPLACING FACTOR | Author keyword | 1 | 50% | 0% | 1 |
6 | ANTIGEN SPECIFIC B CELLS | Author keyword | 0 | 20% | 0% | 2 |
7 | B CELL DIFFERENTIATION FACTOR | Author keyword | 0 | 33% | 0% | 1 |
8 | MED INTERNAL MED 1 ITABASHI KU | Address | 0 | 33% | 0% | 1 |
9 | PFC RESPONSE | Author keyword | 0 | 33% | 0% | 1 |
10 | SANDERS BROWN AGING 329 | Address | 0 | 33% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTI IMMUNOGLOBULIN ANTIBODY | 2 | 67% | 0% | 2 |
2 | TNP FICOLL | 2 | 27% | 0% | 6 |
3 | ANTI RECEPTOR ANTIBODY | 2 | 43% | 0% | 3 |
4 | COGNATE INTERACTIONS | 2 | 16% | 1% | 9 |
5 | NONCOGNATE INTERACTION | 1 | 50% | 0% | 2 |
6 | PNU IMUNE VACCINE | 1 | 40% | 0% | 2 |
7 | COWAN I | 1 | 33% | 0% | 2 |
8 | IGM SECRETION | 1 | 21% | 0% | 3 |
9 | ANTIBODY RESPONSES INVITRO | 1 | 50% | 0% | 1 |
10 | BCGF | 1 | 50% | 0% | 1 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY | 2 | 12% | 1% | 15 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
COGNATE INTERACTIONS BETWEEN HELPER T-CELLS AND B-CELLS | 1990 | 142 | 66 | 39% |
REGULATION OF HUMAN LYMPHOCYTE-B ACTIVATION, PROLIFERATION, AND DIFFERENTIATION | 1987 | 130 | 179 | 63% |
FACTORS AFFECTING B-CELL GROWTH AND DIFFERENTIATION | 1985 | 323 | 79 | 73% |
REGULATION OF B-CELL GROWTH AND DIFFERENTIATION BY SOLUBLE FACTORS | 1983 | 543 | 64 | 64% |
FACTORS CONTROLLING THE B-CELL CYCLE | 1986 | 123 | 137 | 57% |
REGULATION OF B-CELL DIFFERENTIATION - INTERACTIONS OF FACTORS AND CORRESPONDING RECEPTORS | 1986 | 63 | 96 | 67% |
CELLULAR INTERACTIONS IN THE HUMORAL IMMUNE-RESPONSE | 1989 | 118 | 450 | 19% |
A REASSESSMENT OF THE MECHANISMS OF ANTIGEN-SPECIFIC T-CELL-DEPENDENT B-CELL ACTIVATION | 1988 | 73 | 46 | 37% |
HUMAN-B LYMPHOCYTES - PHENOTYPE, PROLIFERATION, AND DIFFERENTIATION | 1992 | 180 | 822 | 10% |
HUMAN B-CELL ACTIVATION, PROLIFERATION AND DIFFERENTIATION | 1984 | 157 | 39 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED ICRF HUMAN TUMOUR IMMUNOL GRP | 1 | 50% | 0.1% | 1 |
2 | MED INTERNAL MED 1 ITABASHI KU | 0 | 33% | 0.1% | 1 |
3 | SANDERS BROWN AGING 329 | 0 | 33% | 0.1% | 1 |
4 | HUMAN TUMOUR IMMUNOL GRP | 0 | 20% | 0.1% | 1 |
5 | INSERM U132 | 0 | 14% | 0.1% | 1 |
6 | BIOMED FUKUSHIMA KU | 0 | 100% | 0.1% | 1 |
7 | CLIN IMMUNOL SECT TUMOR BIOL | 0 | 100% | 0.1% | 1 |
8 | CLIN SCI MEDIMPERIAL CANC FUND | 0 | 100% | 0.1% | 1 |
9 | MED CELL GENET HYBRIDOMA GRP | 0 | 100% | 0.1% | 1 |
10 | MED INTERNAL MED 1 CLIN IMMUNOL | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000241888 | SURFACE IGM//IG ALPHA//MEMBRANE IMMUNOGLOBULIN |
2 | 0.0000169070 | VET ANAT PATHOL B14//ACINAR CELL CULTURE//COMPREHENS CANC UNIV STN |
3 | 0.0000151261 | ISOFATTY ACID//COOPERAT MED//MNSF BETA |
4 | 0.0000136084 | U396//HU1D10//UNITE 396 |
5 | 0.0000130376 | XYMEDON//ANTIGEN PURIFICATION//BIOL KAZAN |
6 | 0.0000129124 | ANTIGEN FREE MICE//X RAYS EXPOSURE//PGP 1 |
7 | 0.0000126973 | ALKALINE PHOSPHATE ACTIVITY//IN VIVO SENSITIZATION//SYNTHETIC LIPID |
8 | 0.0000115078 | T LYMPHOCYTE IMMUNOLOGY//CLIN HOSP O NOVOSEL MED MED//MITOGEN INDUCED CELLULAR CYTOTOXICITY |
9 | 0.0000103576 | INTERLEUKIN 2 RECEPTOR//IL 2 RECEPTOR//IL 2 RECEPTOR GAMMA CHAIN |
10 | 0.0000102794 | ALLOANTIGEN SPECIFIC CYTOTOXIC T LYMPHOCYTES//ALPHA BETA TCR TRANSGENE//FOOTPAD IMMUNIZATION |